In silico Identification of Multi-Target Phytochemicals from Artemisia annua and Aloe barbadensis Against Methicillin-Resistant Staphylococcus aureus
DOI:
https://doi.org/10.51867/ajernet.chem.7.1.131Keywords:
Aloe barbadensis, Artemisia annua, Drug Likeness, Molecular Docking, MRSA, Multi Target, MurAAbstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of healthcare-associated infections with limited treatment options due to multidrug resistance. Medicinal plants Artemisia annua and Aloe barbadensis have demonstrated antibacterial activity, but the specific bioactive compounds and their molecular targets remain largely unknown. This study employed molecular docking to screen 61 drug‑like phytochemicals (33 from A. annua, 28 from A. barbadensis) against eleven MRSA protein targets involved in cell‑wall synthesis (PBP2a, MurA, MurB, FemA/FemB, LtaS), DNA replication (DNA gyrase, topoisomerase IV), folate metabolism (DHFR, DHPS), virulence (sortase A), and stress response (ClpP). AutoDock Vina was used to calculate binding affinities, and Lipinski’s Rule of Five was applied to assess drug‑likeness. Twenty‑eight compounds showed binding affinities ≤ −7.0 kcal/mol against at least one target. Aloesaponarin I (from A. barbadensis) exhibited the strongest interaction with MurB (−10.5 kcal/mol). Other high‑affinity compounds included 7‑O‑methylaloesin (MurA, −9.4 kcal/mol; LtaS, −8.8 kcal/mol), aloesaponol I (DHFR, −9.3 kcal/mol), and luteolin (sortase A, −7.7 kcal/mol; DNA gyrase, −7.7 kcal/mol). MurA was the most frequently inhibited target (23 compounds with ΔG ≤ −8.0 kcal/mol). All active compounds satisfied Lipinski’s criteria, indicating favorable oral bioavailability. These findings identify aloesaponarin I, 7‑O‑methylaloesin, luteolin, and kaempferol as promising multi‑target MRSA inhibitors, warranting further in vitro and in vivo validation. The study recommends that future work should focus on determination of MIC and MBC for the top compounds (aloesaponarin I, 7‑O‑methylaloesin, luteolin, kaempferol) against MRSA clinical isolates as well as molecular dynamics simulations of the best complexes together with related synergies.
Downloads
References
Benson, T. E., Filman, D. J., Walsh, C. T., & Hogle, J. M. (1996). The crystal structure of MurB, a key enzyme in bacterial peptidoglycan synthesis. Nature Structural Biology, 3(3), 290-294. https://doi.org/10.1038/nsb0396-290
Bilia, A. R. (2014). Essential oil of Artemisia annua L.: An extraordinary component with numerous antimicrobial properties. Evidence-Based Complementary and Alternative Medicine, 2014, 159819. https://doi.org/10.1155/2014/159819
Bordean, M. E., Ungur, R. A., Toc, D. A., Borda, I. M., Marțiș, G. S., Pop, C. R., Filip, M., Vlassa, M., Nasui, B. A., Pop, A., Cinteză, D., Popa, F. L., Marian, S., Szanto, L. G., & Muste, S. (2023). Antibacterial and phytochemical screening of Artemisia species. Antioxidants, 12(3), 596. https://doi.org/10.3390/antiox12030596
Brown, E. D., & Wright, G. D. (2016). Antibacterial drug discovery in the resistance era. Nature, 529(7586), 336-343.
https://doi.org/10.1038/nature17042
Chan, P. F., Srikannathasan, V., Huang, J., Cui, H., Fosberry, A. P., Gu, M., Hann, M. M., Hibbs, M., Homes, P., Ingraham, K., Pizzollo, J., Shen, C., Shillings, A. J., Spitzfaden, C. E., Tanner, R., Theobald, A. J., Stavenger, R. A., Bax, B. D., & Gwynn, M. N. (2019). Structural basis of DNA gyrase inhibition by antibacterial QPT-1, a quinazolinedione derivative. Journal of Medicinal Chemistry, 62(5), 2615-2631. https://doi.org/10.1021/acs.jmedchem.8b01897
Eschenburg, S., Priestman, M. A., & Schönbrunn, E. (2002). Crystal structure of MurA, the target of the antibiotic fosfomycin. Journal of Biological Chemistry, 277(40), 37560-37566. https://doi.org/10.1074/jbc.M204138200
Fiordalisi, S. de A. L., Honorato, L. A., & Kuhnen, S. (2018). Aloe barbadensis Miller leaf exudate is a potential treatment for bovine mastitis. F1000Research, 7, 1285. https://doi.org/10.12688/f1000research.15671.2
Geiger, T., Goerke, C., Fritz, G., Schäfer, T., Ohlsen, K., Liebeke, M., Lalk, M., & Wolz, C. (2011). Role of the (p)ppGpp synthase RSH, a relA/spoT homolog, in stringent response and virulence of Staphylococcus aureus. Infection and Immunity, 79(5), 1879-1889.
https://doi.org/10.1128/IAI.01439-09
Hampele, I. C., D'Arcy, A., Dale, G. E., Kostrewa, D., Nielsen, J., Oefner, C., Page, M. G., Schönfeld, H. J., Stüber, D., & Then, R. L. (1997). Structure and function of the dihydropteroate synthase from Staphylococcus aureus. Journal of Molecular Biology, 268(1), 21-30. https://doi.org/10.1006/jmbi.1997.0944
Heaslet, H., Harris, R., Fahnoe, K., Sarver, R., Putz, H., Chang, J., Subramanyam, C., Barreiro, G., & Miller, J. R. (2009). Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the novel inhibitor trimethoprim. Proteins: Structure, Function, and Bioinformatics, 76(3), 706-717. https://doi.org/10.1002/prot.22383
Kituyi, L., Lutta, S. M., & Barasa, S. (2023). Antimicrobial activity of Artemisia annua L. and Aloe barbadensis Miller plant extracts against Staphylococcus aureus. The Journal of Phytopharmacology, 12(5), 295-298. https://doi.org/10.31254/phyto.2023.12503
Kupnik, K., Primožič, M., Knez, Ž., & Leitgeb, M. (2021). Antimicrobial efficiency of Aloe arborescens and Aloe barbadensis natural and commercial products. Plants, 10(1), 92. https://doi.org/10.3390/plants10010092
Laponogov, I., Sohi, M. K., Veselkov, D. A., Pan, X. S., Sawhney, R., Thompson, A. W., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2010). Structural basis of gate DNA breakage and resealing by type II topoisomerases. PLoS ONE, 5(6), e11338. https://doi.org/10.1371/journal.pone.0011338
Li, F., Lee, S. H., & Kim, K. H. (2021). Crystal structure of LtaS from Staphylococcus aureus reveals a unique active site architecture. Scientific Reports, 11(1), 12587. https://doi.org/10.1038/s41598-021-92043-7
Lim, D., & Strynadka, N. C. J. (2002). Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nature Structural Biology, 9(11), 870-876. https://doi.org/10.1038/nsb858
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3-25. https://doi.org/10.1016/S0169-409X(96)00423-1
Lowy, F. D. (1998). Staphylococcus aureus infections. The New England Journal of Medicine, 339(8), 520-532.
https://doi.org/10.1056/NEJM199808203390806
Millay, D. P., Adams, M. C., & Lee, V. T. (2020). Structure of FemA from Staphylococcus aureus: Insights into pentaglycine bridge formation. Protein Science, 29(7), 1612-1622. https://doi.org/10.1002/pro.3866
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785-2791.
https://doi.org/10.1002/jcc.21256
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/10.1186/1758-2946-3-33
Suree, N., Liew, C. K., Villareal, V. A., Thieu, W., Fadeev, E. A., Clemens, J. J., Jung, M. E., & Clubb, R. T. (2009). The structure of the Staphylococcus aureus sortase substrate complex. Journal of Biological Chemistry, 284(36), 24465-24477. https://doi.org/10.1074/jbc.M109.012328
Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-461. https://doi.org/10.1002/jcc.21334
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1-Causes and threats. Pharmacy and Therapeutics, 40(4), 277-283.
Xiang, H., Cao, F., Ming, D., Zheng, Y., Dong, X., Zhong, X., Mu, D., Li, B., Zhong, L., Cao, J., Wang, L., Ma, H., Wang, T., & Wang, D. (2017). Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development. Applied Microbiology and Biotechnology, 101(17), 6671-6681. https://doi.org/10.1007/s00253-017-8403-5
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Loice Naswa Wechuli, Stephen S. Barasa, Naomi Bisem, Kituyi John Lusweti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.













